BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 34245598)

  • 1. The SARS-CoV-2 pandemic is associated with increased severity of presentation of childhood onset type 1 diabetes mellitus: A multi-centre study of the first COVID-19 wave.
    McGlacken-Byrne SM; Drew SEV; Turner K; Peters C; Amin R
    Diabet Med; 2021 Sep; 38(9):e14640. PubMed ID: 34245598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alarming increase in ketoacidosis in children and adolescents with newly diagnosed type 1 diabetes during the first wave of the COVID-19 pandemic in Israel.
    Goldman S; Pinhas-Hamiel O; Weinberg A; Auerbach A; German A; Haim A; Zung A; Brener A; Strich D; Azoulay E; Levy-Khademi F; Ludar H; Koren I; Rachmiel M; Yackobovitch-Gavan M; Zuckerman-Levin N; David O; Halloun R; Cahn R; Ben-Ari T; Yeshayahu Y; Landau Z; Phillip M; Lebenthal Y
    Pediatr Diabetes; 2022 Feb; 23(1):10-18. PubMed ID: 34865288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Severity of Presentation Signs in Children with Newly Diagnosed Type 1 Diabetes during the COVID-19 Pandemic: A Tertiary Center Experience.
    İzci Güllü E; Akin L; Gökler ME; Aydin M
    Ann Nutr Metab; 2024; 80(3):161-170. PubMed ID: 38479369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic ketoacidosis at type 1 diabetes diagnosis in children during the COVID-19 pandemic.
    Ho J; Rosolowsky E; Pacaud D; Huang C; Lemay JA; Brockman N; Rath M; Doulla M
    Pediatr Diabetes; 2021 Jun; 22(4):552-557. PubMed ID: 33745226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Children presenting with diabetes and diabetic ketoacidosis to Emergency Departments during the COVID-19 pandemic in the UK and Ireland: an international retrospective observational study.
    Ponmani C; Nijman RG; Roland D; Barrett M; Hulse T; Whittle V; Lyttle MD;
    Arch Dis Child; 2023 Oct; 108(10):799-807. PubMed ID: 37197894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased frequency of severe diabetic ketoacidosis at type 1 diabetes onset among children during COVID-19 pandemic lockdown: an observational cohort study.
    Dżygało K; Nowaczyk J; Szwilling A; Kowalska A
    Pediatr Endocrinol Diabetes Metab; 2020; 26(4):167-175. PubMed ID: 33554490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of the SARS-CoV-2 Pandemic on Presentation with Diabetic Ketoacidosis in Children with New Onset Type 1 Diabetes Mellitus.
    Jalilova A; Ata A; Demir G; Işıklar H; Atik Altınok Y; Özen S; Darcan Ş; Gökşen D
    J Clin Res Pediatr Endocrinol; 2023 Aug; 15(3):264-267. PubMed ID: 36987789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased paediatric presentations of severe diabetic ketoacidosis in an Australian tertiary centre during the COVID-19 pandemic.
    Lawrence C; Seckold R; Smart C; King BR; Howley P; Feltrin R; Smith TA; Roy R; Lopez P
    Diabet Med; 2021 Jan; 38(1):e14417. PubMed ID: 33020999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Has COVID-19 Delayed the Diagnosis and Worsened the Presentation of Type 1 Diabetes in Children?
    Rabbone I; Schiaffini R; Cherubini V; Maffeis C; Scaramuzza A;
    Diabetes Care; 2020 Nov; 43(11):2870-2872. PubMed ID: 32778554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of COVID-19 Pandemic Lockdown on the Incidence of New-Onset Type 1 Diabetes and Ketoacidosis Among Saudi Children.
    Alaqeel A; Aljuraibah F; Alsuhaibani M; Huneif M; Alsaheel A; Dubayee MA; Alsaedi A; Bakkar A; Alnahari A; Taha A; Alharbi K; Alanazi Y; Almadhi S; Khalifah RA
    Front Endocrinol (Lausanne); 2021; 12():669302. PubMed ID: 33868185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher rates of diabetic ketoacidosis and admission to the paediatric intensive care unit among newly diagnosed children with type 1 diabetes in Kuwait during the COVID-19 pandemic.
    Al-Abdulrazzaq D; Alkandari A; Alhusaini F; Alenazi N; Gujral UP; Narayan KMV; Al-Kandari H;
    Diabetes Metab Res Rev; 2022 Mar; 38(3):e3506. PubMed ID: 34679258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New-onset type 1 diabetes in Finnish children during the COVID-19 pandemic.
    Salmi H; Heinonen S; Hästbacka J; Lääperi M; Rautiainen P; Miettinen PJ; Vapalahti O; Hepojoki J; Knip M
    Arch Dis Child; 2022 Feb; 107(2):180-185. PubMed ID: 34045208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics and outcome of hospitalized children and adolescent patients with type 1 diabetes during the COVID-19 pandemic: data from a single center surveillance study in Egypt.
    Sherif EM; Elhenawy YI; Matter RM; Aly HH; Thabet RA; Fereig YA
    J Pediatr Endocrinol Metab; 2021 Jul; 34(7):925-936. PubMed ID: 33882200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increase in the Diagnosis and Severity of Presentation of Pediatric Type 1 and Type 2 Diabetes during the COVID-19 Pandemic.
    Marks BE; Khilnani A; Meyers A; Flokas ME; Gai J; Monaghan M; Streisand R; Estrada E
    Horm Res Paediatr; 2021; 94(7-8):275-284. PubMed ID: 34564073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetic Ketoacidosis and Long-term Insulin Requirements in Youths with Newly Diagnosed Type 2 Diabetes During the SARS-CoV-2 Pandemic.
    Hao S; Cossen K; Westbrook AL; Umpierrez GE; Vellanki P
    Endocr Pract; 2023 Oct; 29(10):754-761. PubMed ID: 37451650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic ketoacidosis incidence among children with new-onset type 1 diabetes in Poland and its association with COVID-19 outbreak-Two-year cross-sectional national observation by PolPeDiab Study Group.
    Pietrzak I; Michalak A; Seget S; Bednarska M; Beń-Skowronek I; Bossowski A; Chobot A; Dżygało K; Głowińska-Olszewska B; Górnicka M; Horodnicka-Józwa A; Jakubek-Kipa K; Jarosz-Chobot P; Marcinkiewicz K; Mazur A; Myśliwiec M; Nazim J; Niechciał E; Noczyńska A; Rusak E; Seifert M; Skotarczyk-Kowalska E; Skowronek A; Szypowska A; Wais P; Walczak M; Wołoszyn-Durkiewicz A; Wysocka-Mincewicz M; Zubkiewicz-Kucharska A; Szadkowska A
    Pediatr Diabetes; 2022 Nov; 23(7):944-955. PubMed ID: 35700323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketoacidosis in new-onset type 1 diabetes: did the severity increase during the COVID-19 pandemic?
    Botelho TA; Santos JMN; Pinho CMS; Martins AIBR; Formiga AIS; Serra-Caetano J; Cardoso RCF; Dinis ICAD; Mirante ASR
    J Pediatr Endocrinol Metab; 2022 Jan; 35(1):73-77. PubMed ID: 34766743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 Positive Serology and Islet Autoantibodies in Newly Diagnosed Pediatric Cases of Type 1 Diabetes Mellitus: A Single-Center Cohort Study.
    Boboc AA; Novac CN; Marin AG; Ieșanu MI; Plătică C; Buzescu T; Coșoreanu MT; Galoș F
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The global impact of COVID-19 pandemic on the incidence of pediatric new-onset type 1 diabetes and ketoacidosis: A systematic review and meta-analysis.
    Rahmati M; Keshvari M; Mirnasuri S; Yon DK; Lee SW; Il Shin J; Smith L
    J Med Virol; 2022 Nov; 94(11):5112-5127. PubMed ID: 35831242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic Ketoacidosis Severity at Diagnosis and Glycaemic Control in the First Year of Childhood Onset Type 1 Diabetes-A Longitudinal Cohort Study.
    Khanolkar AR; Amin R; Taylor-Robinson D; Viner RM; Warner J; Gevers EF; Stephenson T
    Int J Environ Res Public Health; 2017 Dec; 15(1):. PubMed ID: 29295580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.